Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27

EMBO Journal

Volumn 18, Issue 19, 1999, Pages 5321-5333

  Bouchard, Caroline ^a   Thieke, Katja ^a   Maier, Antje ^a   Saffrich, Rainer ^b   Hanley Hyde, Joan ^c   Ansorge, Wilhelm ^b   Reed, Steve ^c   Sicinski, Piotr ^d   Bartek, Jiri ^e   Eilers, Martin ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e Institute of Cancer Biology   (Denmark)

Author keywords

Cdk2; Cyclin D2; Mad 1; Myc; p27

Indexed keywords

ANTIBODY; CYCLIN D2; HISTONE DEACETYLASE; MESSENGER RNA; PHOSPHOTRANSFERASE; PROTEIN P16; PROTEIN P27; TRICHOSTATIN A;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL IMMORTALIZATION; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENZYME INDUCTION; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; IMMUNOBLOTTING; MOUSE; NONHUMAN; ONCOGENE MYC; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

3T3 CELLS; ANIMALS; BASE SEQUENCE; CELL CYCLE; CELL CYCLE PROTEINS; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DNA PRIMERS; GENE EXPRESSION REGULATION; HUMANS; MICE; MICROTUBULE-ASSOCIATED PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; SEQUENCE HOMOLOGY, NUCLEIC ACID; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA;

EID: 0033214080     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.19.5321     Document Type: Article

References (63)

1. Afar, D.E.H., Goga, A., McLaughlin, J., Witte, O.N. and Sawyers, C.L. (1994) Differential complementation of Bcr-Abl point mutants with c-Myc. Science, 264, 424-426.
2. Afar, D.E.H., McLaughlin, J., Sherr, C.J., Witte, O.N. and Roussel, M.F. (1995) Signaling by ABL oncogenes through cyclin D1. Proc. Natl Acad. Sci. USA, 92, 9540-9544.
3. Alevizopoulos, K., Vlach, J., Hennecke, S. and Amati, B. (1997) Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins. EMBO J., 16, 5322-5333.
4. Alland, L., Muhle, R., Hou, H., Potes, J., Chin, L., Schreiber-Agus, N. and Pinho, R.D. (1997) Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature, 387, 49-55.
5. Ayer, D.E., Kretzner, L. and Eisenman, R.N. (1993) Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell. 72, 211-222.
6. Ayer, D.E., Lawrence, Q.A. and Eisenman, R.N. (1995) Mad-Myc transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell, 80, 767-776.
7. Bartkova, J., Lukas, J., Strauss, M. and Bartek, J. (1998) Cyclin D3: requirement for G1/S transition and high abundance in quiescent tissues suggest a dual role in proliferation and differentiation. Oncogene, 17, 1027-1037.
8. Berns, K., Hijmans, E.M. and Bernards, R. (1997) Repression of c-Myc responsive genes in cycling cells causes G1 arrest through reduction of cyclin E/CDK2 kinase activity. Oncogene, 15, 1347-1356.
9. Bouchard, C., Staller, P. and Eilers, M. (1998) Control of cell proliferation by Myc. Trends Cell Biol., 8, 202-206.
10. Brooks, A.R., Shiffman, D., Chan, C.S., Brooks, E.E. and Milner, P.G. (1996) Functional analysis of the human cyclin D2 and cyclin D3 promoters. J. Biol. Chem., 271, 9090-9099.
11. Davis, A.C., Wims, M., Spotts, G.D., Hann, S.R. and Bradley, A. (1993) A null c-myc mutation causes lethality before 10.5 days of gestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev., 7, 671-682.
12. Desbarats, L., Gaubatz, S. and Eilers, M. (1996) Discrimination between different E-box binding proteins at an endogenous target gene of Myc. Genes Dev., 10, 447-460.
13. Dimri, G.P. et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA, 92, 9363-9367.
14. Draetta, G., Luca, F., Westendorf, J., Brizuela, L., Ruderman, J. and Beach, D. (1989) Cdc2 protein kinase is complexed with both cyclin A and B: evidence for proteolytic inactivation of MPF. Cell, 56, 829-838.
15. Eilers, M., Picard, D., Yamamoto, K. and Bishop, J.M. (1989) Chimaeras between the MYC oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature, 340, 66-68.
16. Eilers, M., Schirm, S. and Bishop, J.M. (1991) The MYC protein activates transcription of the α-prothymosin gene. EMBO J., 10, 133-141.
17. Evan, G.I., Lewis, G.K., Ramsay, G. and Bishop, J.M. (1985) Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol. Cell. Biol., 5, 3610-3616.
18. Evan, G.I., Wyllie, A.H., Gilbert, C.S., Littlewood, T.D., Land, H., Brooks, M., Waters, C.M., Penn, L.Z. and Hancock, D.C. (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128.
19. Grignani, F., Kinsella, T., Mencarelli, A., Valtieri, M., Riganelli, D., Lanfrancone, L., Peschle, C., Nolan, G.P. and Pelicci, P.G. (1998) High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res., 58, 14-19.
20. Harlow, E. and Lane, D. (1988) Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
21. Heinzel, T. et al. (1997) A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature, 387, 43-48.
22. Henriksson, M. and Lüscher, B. (1996) Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res., 68, 109-182.
23. Hermeking, H., Funk, J.O., Reichert, M., Ellwart, J.W. and Eick, D. (1995) Abrogation of p53-induced cell cycle arrest by c-Myc: evidence for an inhibitor of p21WAF1/CIP1/SDI1. Oncogene, 11, 1409-1415.
24. Hurlin, P.J., Queva, C., Koskinen, P.J., Steingrimsson, E., Ayer, D.E., Copeland, N.G., Jenkins, N.A. and Eisenman, R.N. (1996) Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J., 15, 2030-2038.
25. Hurlin, PJ., Queva, C. and Eisenman, R.N. (1997) Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev., 11, 44-58.
26. Jansen-Dürr, R. Meichle, A., Steiner, P., Pagano, M., Finke, K., Botz, J., Wessbecher, J., Draetta, G. and Eilers, M. (1993) Differential modulation of cyclin gene expression by MYC. Proc. Natl Acad. Sci. USA, 90, 3685-3689.
27. Johnston, K.A., Polymenis, M., Wang, S., Branda, J. and Schmidt, E.V. (1998) Novel regulatory factors interacting with the promoter of the gene encoding the mRNA cap binding protein (eIF4E) and their function in growth regulation. Mol. Cell. Biol., 18, 5621-5633.
28. Jun, D.Y., Kim, M.K., Kim, I.G. and Kim, Y.H. (1997) Characterization of the murine cyclin D2 gene: exon/intron organization and promoter activity. Mol. Cell, 7, 537-543.
29. Kanda, T., Sullivan, K.F. and Wahl, G.M. (1998) Histone-GFP fusion protein enables sensitive analysis of chromosome dynamics in living mammalian cells. Curr. Biol., 8, 377-385.
30. Laherty, C.D., Yang, W.-M., Sun, J.-M., Davie, J.R., Seto, E. and Eisenman, R.N. (1997) Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell, 89, 349-356.
31. Leone, G., DeGregori, J., Sears, R., Jakoi, L. and Nevins, J.R. (1997) Myc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F. Nature, 387, 422-426.
32. Litllewood, T.D., Hancock, D.C., Danielian, P.S., Parker, M.G. and Evan, G.I. (1995) A modified oestrogen receptor ligand binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res., 23, 1686-1690.
33. Lukas, J., Bartkova, J., Welcker, M., Petersen, O.W., Peters, G., Strauss, M. and Bartek, J. (1995) Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types. Oncogene, 10, 2125-2134.
34. Mateyak, M.K., Obaya, A.J. and Sedivy, J.M. (1999) c-Myc regulates cyclin D-cdk4 and -cdk6 activity but affects cell cycle progression at multiple independent points. Mol. Cell. Biol., 19, 4672-4683.
35. McMahon, S.B., Van Buskirk, H.A., Dugan, K.A., Copeland, T.D. and Cole, M.D. (1998) The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell, 94, 363-374.
36. Meroni, G. et al. (1997) Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J., 16, 2892-2906.
37. Meyyappan, M., Wong, H., Hull, C. and Riabowol, K.T. (1998) Increased expression of cyclin D2 during multiple states of growth arrest in primary and established cells. Mol. Cell. Biol., 18, 3163-3172.
38. Morgenstern, J.P. and Land, H. (1990) Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18, 3587-3596.
39. Müller, D., Bouchard, C., Rudolph, B., Steiner, P., Stuckmann, I., Saffrich, R., Ansorge, W., Huttner, W. and Eilers, M. (1997) Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene, 15, 2561-2576.
40. Pear, W.S., Nolan, G.P., Scott, M.L. and Baltimore, D. (1993) Production of high-titer helper-free retroviruses by transient transfection. Proc. Natl Acad. Sci. USA, 90, 8392-8396.
41. Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66.
42. Prall, O.W.J., Rogan, E.M., Musgrove, E.A., Watts, C.K.W. and Sutherland, R.L. (1998) c-Myc or cyclin D1 mimics estrogen effects on cyclin E-cdk2 activation and cell cycle reentry. Mol. Cell. Biol., 18, 4499-4508.
43. Pusch, O., Bernaschek, G., Eilers, M. and Hengstschlager, M. (1997) Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases. Oncogene, 15, 649-656.
44. Reynisdottir, I., Polyak, K., Iavarone, A. and Massague, J. (1995) Kip/Cip and lnk4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9, 1831-1845.
45. Roussel, M.F., Cleveland, J.L., Shurtleff, S.A. and Sherr, C.J. (1991) Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature, 353, 361-363.
46. Roussel, M.F. Theodoras, A.M., Pagano, M. and Sherr, C.J. (1995) Rescue of defective mitogenic signaling by D-type cyclins. Proc. Natl Acad. Sci. USA, 92, 6837-6841.
47. Roussel, M.F., Ashmun, R.A., Sherr, C.J., Eisenman, R.N. and Ayer, D.E. (1996) Inhibition of cell proliferation by the Mad1 transcriptional repressor. Mol. Cell. Biol., 16, 2796-2801.
48. Rudolph, B., Zwicker, J., Saffrich, R., Henglein, B., Müller, R., Ansorge, W. and Eilers, M. (1996) Activation of cyclin dependent kinases by Myc mediates transcriptional activation of cyclin A. but not apoptosis. EMBO J., 15, 3065-3076.
49. Sawadogo, M., Van Dyke, M.W., Gregor, P.D. and Roeder, R.G. (1988) Multiple forms of the human gene-specific transcription factor USF. I. Complete purification and identification of USF from HeLa cell nuclei. J. Biol. Chem., 263, 11985-11993.
50. Schreiber-Agus, N., Chin, L., Chen, K., Torres, R., Rao, G., Guida, P., Skoultchi, A.I. and DePinho, R.A. (1995) An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell, 80, 777-786.
51. Schreiber-Agus, N., Meng, Y., Hoang, T., Hou, H., Jr, Chen, K., Greenberg, R., Cordon-Cardo, C., Lee, H.W. and DePinho, R.A. (1998) Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature, 393, 483-487.
52. Serrano, M., Gomez Lahoz, E., DePinho, R.A., Beach, D. and Bar Sagi, D. (1995) Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science, 267, 249-252.
53. Sherr, C.J. and Roberts, J.M. (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev., 9, 1149-1163.
54. Sicinski, P. et al. (1996) Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature, 384, 470-474.
55. Sommer, A., Hilfenhaus, S., Menkel, A., Kremmer, E., Seiser, C., Loidl, P. and Lüscher, B. (1997) Cell growth inhibiiton by the Mad/Max complex through recruitment of histone deacetylase activity. Curr. Biol., 7, 357-365.
56. Spotts, G.D., Patel, S.V., Xiao, Q. and Hann, S.R. (1997) Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol. Cell. Biol., 17, 1459-1468.
57. Steiner, P., Philipp, A., Lukas, J., Godden-Kent, D., Pagano, M., Mittnacht, S., Bartek, J. and Eilers, M. (1995) Identification of a Myc-dependent step during the formation of active G1 cyclin/cdk complexes. EMBO J., 14, 4814-4826.
58. Toyoshima, H. and Hunter, T. (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74.
59. Vlach, J., Hennecke, S., Alevizopoulos, K., Conti, D. and Amati, B. (1996) Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J., 15, 6595-6604.
60. waf1/cip1. Genes Dev., 8, 2817-2830.
61. Xiao, Q., Claassen, G., Shi, J., Adachi, S., Sedivy, J. and Hann, S.R. (1998) Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis. Genes Dev., 12, 3803-3808.
62. Yang, M., Hosokawa, Y., Hu, Y., Kaneko, S., Kaneko, H., Tanaka, M. and Nakashima, K. (1997) Cloning and functional analysis of rat cyclin D2 promoter: multiple prolactin-responsive elements. Biochem. Mol. Biol. Int., 43, 749-754.
63. Zervos, J., Gyuris, A.S. and Brent, R. (1993) Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell, 72, 223-232.